article thumbnail

USA: MDMA Inches Toward FDA Approval for the Treatment of PTSD

Cannabis Law Report

Emerald Magazine reports… The drug 3,4-Methylenedioxymethamphetamine, also known as MDMA or ”Molly,” is a schedule I drug with no current… Read More.

article thumbnail

New Issue of the ASA Activist Newsletter is out!

Americans for Safe Access

You'll also find a link to the new issue of Cannabis Patient Care Magazine, a free benefit to ASA members, that this month features important information about coping with breast cancer treatment.

Events 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

1 in 5 caregivers treat their autistic children with CBD, survey finds

The Cannigma

One in five caregivers of children with autism give them CBD as a form of treatment, and 31% started CBD treatment during the COVID-19 pandemic, according to a new survey from Autism Parenting Magazine. The survey was carried out by emails sent to the magazine’s subscribers. The magazine also noted that only 7.4%

CBD 143
article thumbnail

The Canadian Lawyer Magazine Publishes Article – “Special Feature: The psychedelic revolution has arrived”

Cannabis Law Report

Health professionals are increasingly turning their attention towards the impact of the COVID-19 pandemic on mental health — and new research is shedding light into the potential benefits of psychedelic treatments. As the psychedelic revolution has arrived, there are numerous ways that innovators can protect these innovations.

article thumbnail

Psychedelic Research Potpourri

Project CBD

He told me he hadn’t read as much coverage of psychedelics in popular magazines and other mainstream outlets lately, and asked whether research has slowed. Seven of the 40 participants reported treatment-related anxiety, and four dropped out as a result. And if so, what ethical challenges would be involved in such a treatment?

article thumbnail

Switzerland: National Council simplifies access to medical cannabis

Cannabis Law Report

Hanf magazine reports. Treatment with medical cannabis will no longer require a special permit. It is still unclear whether the health insurance will pay for … Read More. The post Switzerland: National Council simplifies access to medical cannabis first appeared on Cannabis Law Report.

Access 69
article thumbnail

The Guardian: MAPS MDMA trials under review in Canada over alleged abuse of study participants

Cannabis Law Report

In May 2021, it released results from a phase-three trial in the journal Nature on the benefits of the drug – commonly sold illegally as a powder or within ecstasy tablets – as a breakthrough treatment for PTSD, for which there is currently no effective pharmaceutical treatment. Read the full article.